Recent reports have further confirmed CD123 overexpression in HCL but showed partial/dim CD123 expression in 40% of HCL variant, 33% of MCL, 33% of FL, 25% of SMZL, and 4% of CLL [56]. This evidence concerns the gene IL3RA and B-cell chronic lymphocytic leukemia.